Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 2
2005 5
2006 3
2007 4
2008 1
2009 2
2011 1
2012 1
2014 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy.
Yoshifuji A, Ryuzaki M, Uehara Y, Ohmagari N, Kawai T, Kanno Y, Kikuchi K, Kon H, Sakai K, Shinoda T, Takano Y, Tanaka J, Hora K, Nakazawa Y, Hasegawa N, Hanafusa N, Hinoshita F, Morikane K, Wakino S, Nakamoto H, Takemoto Y. Yoshifuji A, et al. Among authors: hora k. Ren Replace Ther. 2022;8(1):18. doi: 10.1186/s41100-022-00405-8. Epub 2022 Apr 25. Ren Replace Ther. 2022. PMID: 35494536 Free PMC article.
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.
Yoshifuji A, Toda M, Ryuzaki M, Kikuchi K, Kawai T, Sakai K, Oyama E, Koinuma M, Katayama K, Uehara Y, Ohmagari N, Kanno Y, Kon H, Shinoda T, Takano Y, Tanaka J, Hora K, Nakazawa Y, Hasegawa N, Hanafusa N, Hinoshita F, Morikane K, Wakino S, Nakamoto H, Takemoto Y. Yoshifuji A, et al. Among authors: hora k. Ren Replace Ther. 2022;8(1):39. doi: 10.1186/s41100-022-00427-2. Epub 2022 Aug 19. Ren Replace Ther. 2022. PMID: 35999867 Free PMC article.
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis.
Yoshifuji A, Toda M, Ryuzaki M, Oyama E, Kikuchi K, Kawai T, Sakai K, Koinuma M, Katayama K, Yokoyama T, Uehara Y, Ohmagari N, Kanno Y, Kon H, Shinoda T, Takano Y, Tanaka J, Hora K, Nakazawa Y, Hasegawa N, Hanafusa N, Hinoshita F, Morikane K, Wakino S, Nakamoto H, Takemoto Y. Yoshifuji A, et al. Among authors: hora k. Vaccines (Basel). 2023 Mar 14;11(3):653. doi: 10.3390/vaccines11030653. Vaccines (Basel). 2023. PMID: 36992238 Free PMC article.
PPARalpha protects proximal tubular cells from acute fatty acid toxicity.
Kamijo Y, Hora K, Kono K, Takahashi K, Higuchi M, Ehara T, Kiyosawa K, Shigematsu H, Gonzalez FJ, Aoyama T. Kamijo Y, et al. Among authors: hora k. J Am Soc Nephrol. 2007 Dec;18(12):3089-100. doi: 10.1681/ASN.2007020238. Epub 2007 Oct 31. J Am Soc Nephrol. 2007. PMID: 17978304 No abstract available.
Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T. Kikuchi K, et al. Among authors: hora k. Ther Apher Dial. 2014 Dec;18(6):603-11. doi: 10.1111/1744-9987.12189. Epub 2014 Sep 4. Ther Apher Dial. 2014. PMID: 25196061 Clinical Trial.
29 results